Late-stage CKD drug demand is rising sharply as chronic kidney disease becomes increasingly common worldwide. The Insight Partners reports Late Stage Chronic Kidney Disease Drugs Market, valued at USD 5.74 billion in 2021, is projected to expand to USD 17.95 billion by 2031, registering a CAGR of 12.2%. This growth is fueled by growing healthcare requirements, reimbursement support, and...